The Most Active Penny Stocks in 2024

Intelligent Bio Solutions Inc. is a life sciences company, founded in 2016 with headquarters in New York and is engaged in performing diagnostic tests, real-time monitoring, and non-invasive surgery for its patients. The firm has developed a CoV-2 Biosensor, which can be used in RNA virus detection.

This penny stock has an average trading volume of 18.977 million. It’s a potentially good investment because the company is actively developing its technologies, and a breakthrough could lead to strong investor interest.

TScan Therapeutics is a pre-clinical-stage biopharmaceutical company founded in 2018, with headquarters in Waltham, Massachusetts. It develops T-cell therapies to treat cancer patients and focuses on developing vaccines to fight diseases such as SARS-CoV-2.

This is one of the most agile penny stocks because an average volume is around 700,000. Furthermore, it has recently received approval from the FDA to use its new investigational drug on several platforms.

The company has a lot of plans for 2023, which may boost the confidence among investors and bring a spike in the penny stock price.

BiondVax Pharmaceuticals is a biopharmaceutical company that focuses on manufacturing immunotherapeutic products for preventing and treating infectious diseases. It was founded in 2003 and established its headquarters in Jerusalem in Israel. The company collaborates with the leading institutions University Medical Center Göttingen and Max Planck Society.

The penny stock has an average trading volume of around $250,000, and investors should be pleased with recent breakthroughs by the company. A preclinical proof-of-concept study was released regarding the inhaled NanoAb Covid drug with positive results.

Also, BiondVax Pharmaceuticals is anticipating more milestones during 2023, which could increase the penny stock price.

Tritium DCFC Limited is an electric vehicle company that designs, manufactures, and supplies direct current charges. The company is headquartered in Murarrie, Australia, and serves Europe, North America, and Asia Pacific by offering multiple charging stations, including 50, 75, 150, 175, and 350-kilowatt chargers.

The company has an average trading volume of $8.714 million, and it recently announced one of the biggest orders in its history. BP made the order to accelerate the development of EV chargers. Hence, this sale should boost confidence among investors which will further result in a rise in the price of penny stock.

RYVYL Inc. is a technology company that focuses on blockchain-based payment solutions. Their systems facilitate, record, and store a volume of tokenized assets. Their flagship product is QuickCard Payment System, POS Solutions, and the Loopz software solution. The company was incorporated in 2007 under its previous name, ASAP Expo, Inc. with headquarters in San Diego, California.

The average trading volume of this high-volume penny stock is around $580,000 which has a lot of upside because of recent news that it has plans to address the illegal short-selling of its stock to protect current investors. This can potentially increase investor trust in the company stock, which can attract more investment.

Baudax Bio was incorporated in 2019 with headquarters in Malvern, Pennsylvania. It is a pharmaceutical company that focuses on products for hospitals and other acute care settings. Among their flagship products is the ANJESO injection, which helps patients in managing moderate to extreme pain. Other products the company is developing may lead to breakthroughs in the medical field, which could lead to a massive increase in this high-volume penny stock’s price.

Furthermore, this penny stock has an active trading volume of 5.219 million and is flying under big investors' radar. Therefore, getting in early on the ground level may result in big returns if the company gains traction.

Compugen is a clinical-stage therapeutic discovery and development company, doing innovative research and manufacturing therapeutic products in the medical field. Advancements in product development could lead to a rise in the stock price, which makes this a good active penny stock. The firm has recently collaborated with Johns Hopkins University for myeloid and signed an agreement with AstraZeneca to develop antibody products.

The average trading volume of Compugen is around $670.799K, and the consensus target price is $6.14, which is an upside of 607.46%. Many analysts agree that Compugen is an investable penny stock because of the company’s promising work.

Organigram Holdings Inc. is involved in producing and selling cannabis-related products such as cannabis oils, gummies, and cannabis flowers in Canada. The company was incorporated in 2010 with its headquarters in Toronto, Canada.

The average trading volume of Organigram Holdings Inc. is $1.635 million, which suggests there is a lot of interest in high-volume penny stock. The 12-month price target for the stock is 1.51, which represents an increase of 64.55%, hence, it could bring potentially good returns.

Geron Corporation, incorporated in 1990, is a late-stage clinical biopharmaceutical company involved in the therapeutics for myeloid hematologic malignancies. The medical company has had promising results in its late-stage studies, which is a positive sign for investors looking to invest. The headquarters are located in Foster City, California.

The average trading volume of this high-volume penny stock is 5.792 million and the 1-year price target is $5.33, which is an upside of 59.68%. Furthermore, the consensus says that this uncommon penny stock is a strong buy due to its stability.

Ardelyx is a biopharmaceutical company that provides medicines for treating gastrointestinal and cardiorenal therapeutic areas. The company’s flagship product is tenapanor, which has passed phase 3 clinical trials and focuses on treating irritable bowel syndrome. Additionally, Ardelyx was incorporated in 2007 and its headquarters are in Waltham, Massachusetts.

The average trading volume for the active penny stock is 7.707 million and the 12-month price target is $5.75, which is a 101.75% upside.

New penny stocks, which refer to penny stocks that have recently gone public or are newly listed on a stock exchange, can be quite active. The level of activity of a new penny stock will depend on various factors such as the company's financial performance, growth potential, industry trends, and overall market conditions.

	Name	Score	Visit	Disclaimer
	TradeStation	6.5	Visittradestation.com

Headquartered at Plantation in Florida, TradeStation consistently ranks as one of the best stock trading platforms and has won multiple industry awards. The platform’s highlights include an intuitive user interface, quick trading, and a highly-rated mobile app that allows you to trade on the move. TradeStation offers some of the best research and technical analysis tools in the industry, enabling beginners to use market insights, community forums, and webinars to improve their trading skills.

	Name	Score	Visit	Disclaimer
	Fidelity	6.5	Visitfidelity.co.uk

Fidelity is an excellent stock trading platform that regularly tops the charts on lists across the world wide web. The company’s founder is Edward C. Johnson II and CEO is Abigail Johnson. It was founded in 1946 with headquarters in Boston, Massachusetts and currently, it has 57,000 employees.

The analysis and research tools can be accessed by using the Fidelity Active Trader Pro platform which makes it easy to locate penny stocks that could bring higher ROI. However, customers must complete a minimum of 36 trades every 12 months to continue using the features.

This section summarizes the pros and cons of trading penny stocks;